{
  "id": "mhgap#risk_safety_7848161a",
  "content": "facial, bulbar, respiratory, and proximal limb muscles.\nInformed consent The process by which the health care provider discloses appropriate\nNeonatal abstinence Intrauterine exposure to addictive drugs can lead to neonatal\ninformation to a person who can then make a voluntary choice to accept or\nsyndrome withdrawal symptoms. Withdrawal symptoms are usually\nrefuse treatment. informed consent includes a discussion of the following\nneurological, preventing normal autonomic function. The clinical\nelements: the nature of the decision/procedure; reasonable alternatives to\npresentation of drug withdrawal is variable and dependent on several\nthe proposed intervention; the relevant risks, benefits, and uncertainties\nfactors, such as, the type and dose of drug used, and rate of\nrelated to each alternative; assessment of the person’s understanding, and\nmetabolism and excretion of the mother and infant.\nthe acceptance of the intervention by the person.\nNeuroinfection Infection involving the brain and/or spinal cord.\nInterpersonal therapy Psychological treatment that focuses on the link between depressive\n(IPT) symptoms and interpersonal problems, especially those involving Neuroleptic malignant A rare but life-threatening condition caused by antipsychotic\ngrief, disputes, life changes and social isolation. It is also known as syndrome (NMS) medications, which is characterised by fever, delirium, muscular",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "emotions",
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety facial, bulbar, respiratory, and proximal limb muscles.\nInformed consent The process by which the health care provider discloses appropriate\nNeonatal abstinence Intrauterine exposure to addictive drugs can lead to neonatal\ninformation to a person who can then make a voluntary choice to accept or\nsyndrome withdrawal symptoms. Withdrawal symptoms are usually\nrefuse treatment. informed consent includes a discussion of the following\nneurological, preventing normal autonomic function. The clinical\nelements: the nature of the decision/procedure; reasonable alternatives to\npresentation of drug withdrawal is variable and dependent on several\nthe proposed intervention; the relevant risks, benefits, and uncertainties\nfactors, such as, the type and dose of drug used, and rate of\nrelated to each alternative; assessment of the person’s understanding, and\nmetabolism and excretion of the mother and infant.\nthe acceptance of the intervention by the person.\nNeuroinfection Infection involving the brain and/or spinal cord.\nInterpersonal therapy Psychological treatment that focuses on the link between depressive\n(IPT) symptoms and interpersonal problems, especially those involving Neuroleptic malignant A rare but life-threatening condition caused by antipsychotic\ngrief, disputes, life changes and social isolation. It is also known as syndrome (NMS) medications, which is characterised by fever, delirium, muscular Facial, bulbar, respiratory, and proximal limb muscles. informed consent the process by which the health care provider discloses appropriate\nneonatal abstinence intrauterine exposure to addictive drugs can lead to neonat..."
}